CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: Regarding chronic myelogenous leukemia (CML), the Twist1 expression level in CD34+ CML cells acted as a prognostic factor and also a biomarker for early detection of tyrosine kinase inhibitor resistance irrespective of any other resistance mechanism.